TRST
HEXO Q2 2019 Earnings – On the Edge of Profitability
A full review of HEXO (TSE: HEXO) Q2 2019 earnings. Should you buy this value priced name or are there…
CannTrust Files $700 Million Base Shelf Prospectus
After reaching the critical threshold of listing on the New York Stock Exchange last month, Ontario-based medical cannabis company CannTrust Holdings Inc. (TSX:TRST; NYSE:…
CannTrust Holdings to List Stock CTST on NYSE Starting Monday
Following in the wake of major licensed producers such as Aurora and Aphria, medical and recreational cannabis producer CannTrust Holdings (TSX: TRST) has…
CannTrust Recruits New CFO to Deepen Leadership Team
After two years of leading the company’s financial team, former Chief Financial Officer Ian Abramowitz of CannTrust Holdings (TSX: TRST)…
Canopy Growth Q2 2019 Earnings Review – Big Growth With a Big Cost Structure to Match
Bottom Line: Investors will probably like this earnings release from Canopy Growth (TSE: WEED; NYSE: CGC). Net revenue of $83…
Aurora Cannabis Q2 2019 Earnings Review – Recreational Ramp Slower Than Expected
Bottom Line Aurora has arrived as a major player in the recreational market capturing ~20% market share of rec volumes…
Tilray Q3 2018 Earnings – Is the Hype Justified?
Bottom Line This was the second quarter we got to see what Tilray is all about and we couldn't find…
GMP Slashes Canopy Estimates – More Noise than Signal
Big Revenue Change from a Big Cannabis Broker GMP Securities, the go-to bank for the cannabis industry, downgraded its 2019…
Pot Stocks Plunge After Canadian Legalization — Where to Now?
The old investing adage 'buy the rumour, sell the news' befits cannabis equities rather well right now. In Canada recreational…